Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NuclixBio and PharmAbcine enter collaborative research agreement

March 15, 2022

Series A financing at Scenic Biotech to support immuno-oncology and rare inherited disease pipeline

March 10, 2022

Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells

March 7, 2022

EBV antibodies put to good use through retargeting

Feb. 18, 2022

Adcentrx and AvantGen partner to discover antibodies for ADC candidates

Feb. 15, 2022

Researchers present novel capsule-mediated gastrointestinal mRNA delivery approach

Feb. 8, 2022

eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination

Feb. 7, 2022

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

Subcutaneous nanocarrier-mediated delivery of rapamycin

Jan. 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.